Global Bone Marrow Transplant Rejection Treatment Market Status and Outlook 2018-2025

August 2018 | 146 pages | ID: GDC0DC77400EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Bellicum Pharmaceuticals, Inc.
• Bio-Cancer Treatment International Limited
• Biogen Inc
• Boryung Pharmaceutical Co., Ltd.
• Bristol-Myers Squibb Company
• Cantex Pharmaceuticals, Inc.
• Capricor Therapeutics, Inc.
• Cell Source, Inc.
• Cell2B S.A.
• CellECT Bio, Inc.
• Cleveland BioLabs, Inc.
• Compugen Ltd.
• Cynata Therapeutics Limited
• Cytodyn Inc.
• Dompe Farmaceutici S.p.A.
• Dr. Falk Pharma GmbH
• Escape Therapeutics, Inc.
• F. Hoffmann-La Roche Ltd.
• Fate Therapeutics, Inc.
• Generon (Shanghai) Corporation Ltd.
• Gilead Sciences, Inc.
• GlaxoSmithKline Plc
• Idera Pharmaceuticals, Inc.

Market by Type

• Azathioprine
• Adrenocorticotropic Hormone
• Cyclophosphamide
• Cyclosporine A
• Others

Market by Application

• Hospital
• Clinic
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Bone Marrow Transplant Rejection Treatment Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Azathioprine
  3.1.2 Adrenocorticotropic Hormone
  3.1.3 Cyclophosphamide
  3.1.4 Cyclosporine A
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital
  4.1.2 Clinic
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Azathioprine Production by Region
    6.1.1.2 Adrenocorticotropic Hormone Production by Region
    6.1.1.3 Cyclophosphamide Production by Region
    6.1.1.4 Cyclosporine A Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital Production by Region
    6.1.2.2 Clinic Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Azathioprine Demand by Region
    6.2.1.2 Adrenocorticotropic Hormone Demand by Region
    6.2.1.3 Cyclophosphamide Demand by Region
    6.2.1.4 Cyclosporine A Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital Demand by Region
    6.2.2.2 Clinic Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Bellicum Pharmaceuticals, Inc.
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Bio-Cancer Treatment International Limited
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Biogen Inc
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Boryung Pharmaceutical Co., Ltd.
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Bristol-Myers Squibb Company
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Cantex Pharmaceuticals, Inc.
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Capricor Therapeutics, Inc.
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Cell Source, Inc.
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Cell2B S.A.
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 CellECT Bio, Inc.
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Cleveland BioLabs, Inc.
8.12 Compugen Ltd.
8.13 Cynata Therapeutics Limited
8.14 Cytodyn Inc.
8.15 Dompe Farmaceutici S.p.A.
8.16 Dr. Falk Pharma GmbH
8.17 Escape Therapeutics, Inc.
8.18 F. Hoffmann-La Roche Ltd.
8.19 Fate Therapeutics, Inc.
8.20 Generon (Shanghai) Corporation Ltd.
8.21 Gilead Sciences, Inc.
8.22 GlaxoSmithKline Plc
8.23 Idera Pharmaceuticals, Inc.

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Bone Marrow Transplant Rejection Treatment Industry Dynamics & Regulations List
Table Global Bone Marrow Transplant Rejection Treatment Sales Revenue, Cost and Margin, 2015-2018E
Table Global Bone Marrow Transplant Rejection Treatment Market Status by Type 2015-2018E, in USD Million
Table Global Bone Marrow Transplant Rejection Treatment Market Status by Application 2015-2018E, in USD Million
Table Global Bone Marrow Transplant Rejection Treatment Market Status by Application 2015-2018E, in Volume
Table Global Bone Marrow Transplant Rejection Treatment Market by Region 2015-2018E, in USD Million
Table Global Bone Marrow Transplant Rejection Treatment Market Share by Region in 2018, in USD Million
Table Global Bone Marrow Transplant Rejection Treatment Market by Region 2015-2018E, in Volume
Table Global Bone Marrow Transplant Rejection Treatment Market Share by Region in 2018, in Volume
Table Azathioprine Production Value by Region 2015-2018E, in USD Million
Table Azathioprine Production Volume by Region 2015-2018E, in Volume
Table Adrenocorticotropic Hormone Production Value by Region 2015-2018E, in USD Million
Table Adrenocorticotropic Hormone Production Volume by Region 2015-2018E, in Volume
Table Cyclophosphamide Production Value by Region 2015-2018E, in USD Million
Table Cyclophosphamide Production Volume by Region 2015-2018E, in Volume
Table Cyclosporine A Production Value by Region 2015-2018E, in USD Million
Table Cyclosporine A Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Azathioprine Market Size by Region 2015-2018E, in USD Million
Table Azathioprine Market Size by Region 2015-2018E, in Volume
Table Adrenocorticotropic Hormone Market Size by Region 2015-2018E, in USD Million
Table Adrenocorticotropic Hormone Market Size by Region 2015-2018E, in Volume
Table Cyclophosphamide Market Size by Region 2015-2018E, in USD Million
Table Cyclophosphamide Market Size by Region 2015-2018E, in Volume
Table Cyclosporine A Market Size by Region 2015-2018E, in USD Million
Table Cyclosporine A Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalBone Marrow Transplant Rejection Treatment Forecast by Type 2019F-2025F, in USD Million
Table Bone Marrow Transplant Rejection Treatment Forecast by Type 2019F-2025F, in Volume
Table Bone Marrow Transplant Rejection Treatment Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Bone Marrow Transplant Rejection Treatment Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Bone Marrow Transplant Rejection Treatment Market Forecast by Region 2019F-2025F, in USD Million
Table Bone Marrow Transplant Rejection Treatment Market Forecast by Region 2019F-2025F, in Volume
Table Bellicum Pharmaceuticals, Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Bellicum Pharmaceuticals, Inc.
Table Bio-Cancer Treatment International Limited Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Bio-Cancer Treatment International Limited
Table Biogen Inc Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Biogen Inc
Table Boryung Pharmaceutical Co., Ltd. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Boryung Pharmaceutical Co., Ltd.
Table Bristol-Myers Squibb Company Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Bristol-Myers Squibb Company
Table Cantex Pharmaceuticals, Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Cantex Pharmaceuticals, Inc.
Table Capricor Therapeutics, Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Capricor Therapeutics, Inc.
Table Cell Source, Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Cell Source, Inc.
Table Cell2B S.A. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Cell2B S.A.
Table CellECT Bio, Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of CellECT Bio, Inc.
Table Cleveland BioLabs, Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Cleveland BioLabs, Inc.
Table Compugen Ltd. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Compugen Ltd.
Table Cynata Therapeutics Limited Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Cynata Therapeutics Limited
Table Cytodyn Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Cytodyn Inc.
Table Dompe Farmaceutici S.p.A. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Dompe Farmaceutici S.p.A.
Table Dr. Falk Pharma GmbH Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Dr. Falk Pharma GmbH
Table Escape Therapeutics, Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Escape Therapeutics, Inc.
Table F. Hoffmann-La Roche Ltd. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of F. Hoffmann-La Roche Ltd.
Table Fate Therapeutics, Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Fate Therapeutics, Inc.
Table Generon (Shanghai) Corporation Ltd. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Generon (Shanghai) Corporation Ltd.
Table Gilead Sciences, Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Gilead Sciences, Inc.
Table GlaxoSmithKline Plc Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of GlaxoSmithKline Plc
Table Idera Pharmaceuticals, Inc. Information
Table Bone Marrow Transplant Rejection Treatment Sales, Cost, Margin of Idera Pharmaceuticals, Inc.
Table Global Bone Marrow Transplant Rejection Treatment Sales Revenue by Company 2015-2017, in USD Million
Table Global Bone Marrow Transplant Rejection Treatment Sales Volume by Company 2015-2017, in Volume
Table Global Bone Marrow Transplant Rejection Treatment Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Bone Marrow Transplant Rejection Treatment Picture
Figure Bone Marrow Transplant Rejection Treatment Industry Chain Diagram
Figure Global Bone Marrow Transplant Rejection Treatment Sales Revenue 2015-2018E, in USD Million
Figure Global Bone Marrow Transplant Rejection Treatment Sales Volume 2015-2018E, in Volume
Figure Global Bone Marrow Transplant Rejection Treatment Market Status by Type 2015-2018E, in Volume
Figure North America Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in USD Million
Figure North America Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in Volume
Figure Europe Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Europe Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in Volume
Figure South America Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in USD Million
Figure South America Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in Volume
Figure Middle East Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in Volume
Figure Africa Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Africa Bone Marrow Transplant Rejection Treatment Market Size and Growth 2015-2018E, in Volume
Figure Global Bone Marrow Transplant Rejection Treatment Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Bone Marrow Transplant Rejection Treatment Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Bone Marrow Transplant Rejection Treatment Sales Price Forecast 2019F-2025F
Figure Global Bone Marrow Transplant Rejection Treatment Gross Margin Forecast 2019F-2025F
Figure Global Bone Marrow Transplant Rejection Treatment Sales Revenue by Company in 2018, in USD Million
Figure Global Bone Marrow Transplant Rejection Treatment Price by Company in 2018
Figure Global Bone Marrow Transplant Rejection Treatment Gross Margin by Company in 2018